Optimal route for human umbilical cord blood-derived mesenchymal stem cell transplantation to protect against neonatal hyperoxic lung injury: Gene expression profiles and histopathology

PLoS ONE

Volumn 10, Issue 8, 2015, Pages

  Sung, Dong Kyung ^a   Chang, Yun Sil ^a   Ahn, So Yoon ^a   Sung, Se In ^a   Yoo, Hye Soo ^a   Choi, Soo Jin ^b   Kim, Soo Yoon ^a   Park, Won Soon ^a  

^a Samsung Medical Center   (South Korea)

^b MEDIPOST Co Ltd   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CONNECTIVE TISSUE GROWTH FACTOR; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; PROTEIN P53; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; CYTOKINE; MESSENGER RNA; ORGANIC COMPOUND; PKH 26; PROTECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CASPASE 3 GENE; CELL COUNT; CELL DEATH; CELL LABELING; CONNECTIVE TISSUE GROWTH FACTOR GENE; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HISTOPATHOLOGY; HYPEROXIA; HYPEROXIC LUNG INJURY; IMMUNE RESPONSE; INTERLEUKIN 6 GENE; LUNG INJURY; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA GENE; MEAN ALVEOLAR VOLUME; MESENCHYMAL STEM CELL TRANSPLANTATION; MICROARRAY ANALYSIS; NEWBORN; NONHUMAN; PERINATAL PERIOD; PROTEIN P53 GENE; RAT; RESPIRATORY TRACT PARAMETERS; TUMOR NECROSIS FACTOR ALPHA GENE; TUNEL ASSAY; UMBILICAL CORD BLOOD; UPREGULATION; ANIMAL; CYTOLOGY; DNA MICROARRAY; DONOR; FETUS BLOOD; GENETICS; HUMAN; MESENCHYMAL STROMA CELL; METABOLISM; MOLECULAR GENETICS; PATHOLOGY; REPRODUCIBILITY; SPRAGUE DAWLEY RAT; SURVIVAL ANALYSIS; WEIGHT GAIN;

ANIMALS; ANIMALS, NEWBORN; CYTOKINES; FETAL BLOOD; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; HYPEROXIA; IN SITU NICK-END LABELING; INFLAMMATION MEDIATORS; LUNG INJURY; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MOLECULAR SEQUENCE ANNOTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ORGANIC CHEMICALS; PROTECTIVE AGENTS; RATS, SPRAGUE-DAWLEY; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER; SURVIVAL ANALYSIS; TISSUE DONORS; UP-REGULATION; WEIGHT GAIN;

EID: 84942855979     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0135574     Document Type: Article

References (21)

1. Bhandari A, Panitch HB. Pulmonary outcomes in bronchopulmonary dysplasia. Semin Perinatol. 2006;30:219-226. PMID: 16860162
2. Bhandari V, Elias JA. Cytokines in tolerance to hyperoxia-induced injury in the developing and adult lung. Free Radic Biol Med. 2006;41:4-18. PMID: 16781448
3. Bland RD. Neonatal chronic lung disease in the post-surfactant era. Biol Neonate. 2005;88:181-191. PMID: 16210840
4. Chang YS, Oh W, Choi SJ, Sung DK, Kim SY, Choi EY, et al. Human umbilical cord blood-derived mesenchymal stem cells attenuate hyperoxia-induced lung injury in neonatal rats. Cell Transplant. 2009;18:869-886. doi: 10.3727/096368909X471189 PMID: 19500472
5. Chang YS, Choi SJ, Ahn SY, Sung DK, Sung SI, Yoo HS, et al. Timing of umbilical cord blood derived mesenchymal stem cells transplantation determines therapeutic efficacy in the neonatal hyperoxic lung injury. PLoS One. 2013;8:e52419. doi: 10.1371/journal.pone.0052419 PMID: 23349686
6. Chang YS, Choi SJ, Sung DK, Kim SY, Oh W, Yang YS, et al. Intratracheal transplantation of human umbilical cord blood-derived mesenchymal stem cells dose-dependently attenuates hyperoxia-induced lung injury in neonatal rats. Cell Transplant. 2011;20:1843-1854. doi: 10.3727/096368911X565038 PMID: 23167961
7. Chang YS, Ahn SY, Yoo HS, Sung SI, Choi SJ, Oh WI, et al. Mesenchymal stem cells for bronchopulmonary dysplasia: phase 1 dose-escalation clinical trial. J Pediatr. 2014;164:966-972 e966. doi: 10. 1016/j.jpeds.2013.12.011 PMID: 24508444
8. Prockop DJ, Oh JY. Medical therapies with adult stem/progenitor cells (MSCs): a backward journey from dramatic results in vivo to the cellular and molecular explanations. J Cell Biochem. 2012;113:1460-1469. doi: 10.1002/jcb.24046 PMID: 22213121
9. Baraniak PR, McDevitt TC. Stem cell paracrine actions and tissue regeneration. Regen Med. 2010;5:121-143. doi: 10.2217/rme.09.74 PMID: 20017699
10. Jang YK, Jung DH, Jung MH, Kim DH, Yoo KH, Sung KW, et al. Mesenchymal stem cells feeder layer from human umbilical cord blood for ex vivo expanded growth and proliferation of hematopoietic progenitor cells. Ann Hematol. 2006;85:212-225. PMID: 16391912
11. Yang SE, Ha CW, Jung M, Jin HJ, Lee M, Song H, et al. Mesenchymal stem/progenitor cells developed in cultures from UC blood. Cytotherapy. 2004;6:476-486. PMID: 15512914
12. Ahn SY, Chang YS, Sung DK, Sung SI, Yoo HS, Lee JH, et al. Mesenchymal stem cells prevent hydrocephalus after severe intraventricular hemorrhage. Stroke. 2013;44:497-504. doi: 10.1161/STROKEAHA.112.679092 PMID: 23287782
13. Grisafi D, Pozzobon M, Dedja A, Vanzo V, Tomanin R, Porzionato A, et al. Human amniotic fluid stem cells protect rat lungs exposed to moderate hyperoxia. Pediatr Pulmonol. 2013;48:1070-1080. doi: 10.1002/ppul.22791 PMID: 23533160
14. O'Reilly M, Thebaud B. Animal models of bronchopulmonary dysplasia. The term rat models. Am J Physiol Lung Cell Mol Physiol. 2014;307:L948-958. doi: 10.1152/ajplung.00160.2014 PMID: 25305248
15. Bucher JR, Roberts RJ. The development of the newborn rat lung in hyperoxia: a dose-response study of lung growth, maturation, and changes in antioxidant enzyme activities. Pediatr Res. 1981;15:999-1008. PMID: 7254958
16. Ahn SY, Chang YS, Kim SY, Sung DK, Kim ES, Rime SY, et al. Long-term (postnatal day 70) outcome and safety of intratracheal transplantation of human umbilical cord blood-derived mesenchymal stem cells in neonatal hyperoxic lung injury. Yonsei Med J. 2013;54:416-424. doi: 10.3349/ymj.2013.54.2. 416 PMID: 23364976
17. Chang YS, Ahn SY, Jeon HB, Sung DK, Kim ES, Sung SI, et al. Critical role of vascular endothelial growth factor secreted by mesenchymal stem cells in hyperoxic lung injury. Am J Respir Cell Mol Biol. 2014;51:391-399. doi: 10.1165/rcmb.2013-0385OC PMID: 24669883
18. Ahn SY, Chang YS, Sung DK, Yoo HS, Sung SI, Choi SJ, et al. Cell type-dependent variation in paracrine potency determines therapeutic efficacy against neonatal hyperoxic lung injury. Cytotherapy. 2015.
19. Aslam M, Baveja R, Liang OD, Fernandez-Gonzalez A, Lee C, Mitsialis SA, et al. Bone marrow stromal cells attenuate lung injury in a murine model of neonatal chronic lung disease. Am J Respir Crit Care Med. 2009;180:1122-1130. doi: 10.1164/rccm.200902-0242OC PMID: 19713447
20. Herault O, Binet C, Rico A, Degenne M, Bernard MC, Chassaigne M, et al. Evaluation of performance of white blood cell reduction filters: an original flow cytometric method for detection and quantification of cell-derived membrane fragments. Cytometry. 2001;45:277-284. PMID: 11746097
21. Goodman RB, Pugin J, Lee JS, Matthay MA. Cytokine-mediated inflammation in acute lung injury. Cytokine Growth Factor Rev. 2003;14:523-535. PMID: 14563354